anti-mesothelin CAR-NKT cell therapy(University of California)

N/A

Report date: 2026/05/08 20:02:52

Base Information

Drug Nameanti-mesothelin CAR-NKT cell therapy(University of California)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > NKT cell therapy > Chimeric antigen receptor NKT cell therapy

Mechanisms of ActionAnti-Mesothelin

TargetsMesothelin

Therapy Area/IndicationsEndometrial Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of California At Los Angeles

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California At Los Angeles

Inactive CompaniesN/A

Active IndicationsEndometrial Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A